Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13

Ultrasound in Obstetrics and Gynecology

Volumn 49, Issue 6, 2017, Pages 714-720

  Santorum, M ^a   Wright, D ^b   Syngelaki, A ^a   Karagioti, N ^a   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

chromosomal abnormalities; first trimester combined test; screening; trisomy 13; trisomy 18; trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; BLOOD; CHROMOSOME 13; CHROMOSOME 18; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FETUS HEART RATE; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE; PREGNANCY; PROSPECTIVE STUDY; REPRODUCIBILITY; TRISOMY; VALIDATION STUDY;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HEART RATE, FETAL; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TRISOMY; ULTRASONOGRAPHY, PRENATAL;

EID: 85018351859     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.17283     Document Type: Article

References (15)

1. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free {beta}-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008; 23: 1968–1975.
2. Snijders RJM, Holzgreve W, Cuckle H, Nicolaides KH. Maternal age-specific risks for trisomies at 9–14 weeks' gestation. Prenat Diagn 1994; 14: 543–552.
3. Snijders RJM, Sebire NJ, Cuckle H, Nicolaides KH. Maternal age and gestational age-specific risks for chromosomal defects. Fetal Diagn Ther 1995; 10: 356–367.
4. Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. Maternal age and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999; 13: 167–170.
5. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376–383.
6. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester screening for trisomy 21 by free beta human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31: 493–502.
7. Wright D, Spencer K, Kagan K, Tørring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH. First-trimester combined screening for trisomy 21 at 7–14 weeks' gestation. Ultrasound Obstet Gynecol 2010; 36: 404–411.
8. Office for National Statistics. Birth Statistics (2000– 2002) Review of the Registrar General on Births and Patterns of Family Building in England and Wales. Series FM1, Nos 29–31. London: Stationary Office.
9. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, LijmerJG Moher D, Rennie D, de Vet HCW, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF, For the STARD Group. STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015; 351: h5527.
10. Robinson HP, Fleming JE. A critical evaluation of sonar crown rump length measurements. Br J Obstet Gynaecol 1975; 182: 702–710.
11. http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-241261
12. R Development Core Team. R. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2011; ISBN 3-900051-07-0. http://www.R-project.org/.
13. Akolekar R, Bower S, Flack N, Bilardo CM, Nicolaides KH. Prediction of miscarriage and stillbirth at 11–13 weeks and the contribution of chorionic villus sampling. Prenat Diagn 2011; 31: 38–45.
14. Syngelaki A, Pergament E, Homfray T, Akolekar R, Nicolaides KH. Replacing the combined test by cell-free DNA testing in screening for trisomies 21, 18 and 13: impact on the diagnosis of other chromosomal abnormalities. Fetal Diagn Ther 2014; 35: 174–84.
15. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 249–266.